<!doctype html><html lang=en-us><head><meta charset=utf-8><meta name=viewport content="width=device-width,initial-scale=1"><meta http-equiv=x-ua-compatible content="IE=edge"><meta name=generator content="Source Themes Academic 4.6.3"><meta name=author content="Raphael Scheible"><meta name=description content="Background Activated phosphoinositide-3-kinase (PI3K) δ Syndrome (APDS) is an inborn error of immunity (IEI) with infection susceptibility and immune dysregulation, clinically overlapping with other conditions. Management depends on disease evolution, but predictors of severe disease are lacking. Objectives Report the extended spectrum of disease manifestations in APDS1 versus APDS2, compare these to CTLA-4 deficiency, NFκB1 deficiency, and STAT3 gain-of-function (GOF) disease; identify predictors of severity in APDS. Methods Data collection with the European Society for Immunodeficiencies (ESID)-APDS registry. Comparison with published cohorts of the other IEIs. Results The analysis of 170 APDS patients outlines high penetrance and early-onset of APDS compared to the other IEIs. The large clinical heterogeneity even in individuals with the same PIK3CD variant E1021K illustrates how poorly the genotype predicts the disease phenotype and course. The high clinical overlap between APDS and the other investigated IEIs suggests relevant pathophysiological convergence of the affected pathways. Preferentially affected organ systems indicate specific pathophysiology: bronchiectasis is typical of APDS1; interstitial lung disease and enteropathy are more common in STAT3 GOF and CTLA-4 deficiency. Endocrinopathies are most frequent in STAT3 GOF, but growth impairment is also common particularly in APDS2. Early clinical presentation is a risk factor for severe disease in APDS. Conclusion APDS illustrates how a single genetic variant can result in a diverse autoimmune-lymphoproliferative phenotype. Overlap with other IEI is substantial. Some specific features distinguish APDS1 from APDS2. Early-onset is a risk factor for severe disease course calling for specific treatment studies in younger patients."><link rel=alternate hreflang=en-us href=https://raphiniert.com/publication/maccari-activated-2023/><meta name=theme-color content=#d9230f><link rel=stylesheet href=https://cdnjs.cloudflare.com/ajax/libs/academicons/1.8.6/css/academicons.min.css integrity="sha256-uFVgMKfistnJAfoCUQigIl+JfUaP47GrRKjf6CTPVmw=" crossorigin=anonymous><link rel=stylesheet href=https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.11.2/css/all.min.css integrity="sha256-+N4/V/SbAFiW1MPBCXnfnP9QSN3+Keu+NlB+0ev/YKQ=" crossorigin=anonymous><link rel=stylesheet href=https://cdnjs.cloudflare.com/ajax/libs/fancybox/3.5.7/jquery.fancybox.min.css integrity="sha256-Vzbj7sDDS/woiFS3uNKo8eIuni59rjyNGtXfstRzStA=" crossorigin=anonymous><link rel=stylesheet href=https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.15.10/styles/github.min.css crossorigin=anonymous title=hl-light><link rel=stylesheet href=https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.15.10/styles/dracula.min.css crossorigin=anonymous title=hl-dark disabled><link rel=stylesheet href=https://cdnjs.cloudflare.com/ajax/libs/leaflet/1.5.1/leaflet.css integrity="sha256-SHMGCYmST46SoyGgo4YR/9AlK1vf3ff84Aq9yK4hdqM=" crossorigin=anonymous><script src=https://cdnjs.cloudflare.com/ajax/libs/lazysizes/5.1.2/lazysizes.min.js integrity="sha256-Md1qLToewPeKjfAHU1zyPwOutccPAm5tahnaw7Osw0A=" crossorigin=anonymous async></script><link rel=stylesheet href="https://fonts.googleapis.com/css?family=Montserrat:400,700%7CRoboto:400,400italic,700%7CRoboto+Mono&display=swap"><link rel=stylesheet href=/css/academic.css><link rel=manifest href=/index.webmanifest><link rel=icon type=image/png href=/img/icon-32.png><link rel=apple-touch-icon type=image/png href=/img/icon-192.png><link rel=canonical href=https://raphiniert.com/publication/maccari-activated-2023/><meta property=twitter:card content=summary><meta property=og:site_name content="Raphael Scheible | Follower of Jesus Christ | Computer Scientist | Researcher - Raphiniert.com"><meta property=og:url content=https://raphiniert.com/publication/maccari-activated-2023/><meta property=og:title content="Activated Phosphoinositide 3-Kinase δ Syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity | Raphael Scheible | Follower of Jesus Christ | Computer Scientist | Researcher - Raphiniert.com"><meta property=og:description content="Background Activated phosphoinositide-3-kinase (PI3K) δ Syndrome (APDS) is an inborn error of immunity (IEI) with infection susceptibility and immune dysregulation, clinically overlapping with other conditions. Management depends on disease evolution, but predictors of severe disease are lacking. Objectives Report the extended spectrum of disease manifestations in APDS1 versus APDS2, compare these to CTLA-4 deficiency, NFκB1 deficiency, and STAT3 gain-of-function (GOF) disease; identify predictors of severity in APDS. Methods Data collection with the European Society for Immunodeficiencies (ESID)-APDS registry. Comparison with published cohorts of the other IEIs. Results The analysis of 170 APDS patients outlines high penetrance and early-onset of APDS compared to the other IEIs. The large clinical heterogeneity even in individuals with the same PIK3CD variant E1021K illustrates how poorly the genotype predicts the disease phenotype and course. The high clinical overlap between APDS and the other investigated IEIs suggests relevant pathophysiological convergence of the affected pathways. Preferentially affected organ systems indicate specific pathophysiology: bronchiectasis is typical of APDS1; interstitial lung disease and enteropathy are more common in STAT3 GOF and CTLA-4 deficiency. Endocrinopathies are most frequent in STAT3 GOF, but growth impairment is also common particularly in APDS2. Early clinical presentation is a risk factor for severe disease in APDS. Conclusion APDS illustrates how a single genetic variant can result in a diverse autoimmune-lymphoproliferative phenotype. Overlap with other IEI is substantial. Some specific features distinguish APDS1 from APDS2. Early-onset is a risk factor for severe disease course calling for specific treatment studies in younger patients."><meta property=og:image content=https://raphiniert.com/img/raphiniert.png><meta property=twitter:image content=https://raphiniert.com/img/raphiniert.png><meta property=og:locale content=en-us><meta property=article:published_time content=2023-12-29T21:10:06&#43;00:00><meta property=article:modified_time content=2023-06-28T00:00:00&#43;00:00><script type=application/ld+json>{"@context":"https://schema.org","@type":"Article","mainEntityOfPage":{"@type":"WebPage","@id":"https://raphiniert.com/publication/maccari-activated-2023/"},"headline":"Activated Phosphoinositide 3-Kinase δ Syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity","datePublished":"2023-12-29T21:10:06Z","dateModified":"2023-06-28T00:00:00Z","author":{"@type":"Person","name":"Maria Elena Maccari"},"publisher":{"@type":"Organization","name":"Raphael Scheible | Follower of Jesus Christ | Computer Scientist | Researcher - Raphiniert.com","logo":{"@type":"ImageObject","url":"https://raphiniert.com/img/raphiniert.png"}},"description":"Background Activated phosphoinositide-3-kinase (PI3K) δ Syndrome (APDS) is an inborn error of immunity (IEI) with infection susceptibility and immune dysregulation, clinically overlapping with other conditions. Management depends on disease evolution, but predictors of severe disease are lacking. Objectives Report the extended spectrum of disease manifestations in APDS1 versus APDS2, compare these to CTLA-4 deficiency, NFκB1 deficiency, and STAT3 gain-of-function (GOF) disease; identify predictors of severity in APDS. Methods Data collection with the European Society for Immunodeficiencies (ESID)-APDS registry. Comparison with published cohorts of the other IEIs. Results The analysis of 170 APDS patients outlines high penetrance and early-onset of APDS compared to the other IEIs. The large clinical heterogeneity even in individuals with the same PIK3CD variant E1021K illustrates how poorly the genotype predicts the disease phenotype and course. The high clinical overlap between APDS and the other investigated IEIs suggests relevant pathophysiological convergence of the affected pathways. Preferentially affected organ systems indicate specific pathophysiology: bronchiectasis is typical of APDS1; interstitial lung disease and enteropathy are more common in STAT3 GOF and CTLA-4 deficiency. Endocrinopathies are most frequent in STAT3 GOF, but growth impairment is also common particularly in APDS2. Early clinical presentation is a risk factor for severe disease in APDS. Conclusion APDS illustrates how a single genetic variant can result in a diverse autoimmune-lymphoproliferative phenotype. Overlap with other IEI is substantial. Some specific features distinguish APDS1 from APDS2. Early-onset is a risk factor for severe disease course calling for specific treatment studies in younger patients."}</script><script src=https://cdnjs.cloudflare.com/ajax/libs/cookieconsent2/3.1.1/cookieconsent.min.js integrity="sha256-5VhCqFam2Cn+yjw61zbBNrbHVJ6SRydPeKopYlngbiQ=" crossorigin=anonymous></script><link rel=stylesheet href=https://cdnjs.cloudflare.com/ajax/libs/cookieconsent2/3.1.1/cookieconsent.min.css integrity="sha256-zQ0LblD/Af8vOppw18+2anxsuaz3pWYyVWi+bTvTH8Q=" crossorigin=anonymous><script>window.addEventListener("load",function(){window.cookieconsent.initialise({"palette":{"popup":{"background":"#d9230f","text":"#fff"},"button":{"background":"#fff","text":"#d9230f"}},"theme":"classic","content":{"message":"This website uses cookies to ensure you get the best experience on our website.","dismiss":"Got it!","link":"Learn more","href":"/privacy/"}})});</script><meta name=google-site-verification content=5FMa7RYkPr6QEWWr1ERvyTkIv5k9JmamL7oeGWeGo9Q><script type=text/javascript>var _paq=window._paq||[];_paq.push(['trackPageView']);_paq.push(['enableLinkTracking']);(function(){var u="//analytics.raphiniert.com/";_paq.push(['setTrackerUrl',u+'schniedel.php']);_paq.push(['setSiteId','2']);var d=document,g=d.createElement('script'),s=d.getElementsByTagName('script')[0];g.type='text/javascript';g.async=true;g.defer=true;g.src=u+'wutz/';s.parentNode.insertBefore(g,s);})();</script><noscript><p><img src="https://analytics.raphiniert.com/schniedel.php?idsite=2&amp;rec=1" style=border:0 alt></p></noscript><title>Activated Phosphoinositide 3-Kinase δ Syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity | Raphael Scheible | Follower of Jesus Christ | Computer Scientist | Researcher - Raphiniert.com</title></head><body id=top data-spy=scroll data-offset=70 data-target=#TableOfContents><aside class=search-results id=search><div class=container><section class=search-header><div class="row no-gutters justify-content-between mb-3"><div class=col-6><h1>Search</h1></div><div class="col-6 col-search-close"><a class=js-search href=#><i class="fas fa-times-circle text-muted" aria-hidden=true></i></a></div></div><div id=search-box><input name=q id=search-query placeholder=Search... autocapitalize=off autocomplete=off autocorrect=off spellcheck=false type=search></div></section><section class=section-search-results><div id=search-hits></div></section></div></aside><nav class="navbar navbar-expand-lg navbar-light compensate-for-scrollbar" id=navbar-main><div class=container><div class="d-none d-lg-inline-flex"><a class=navbar-brand href=/><img src=/img/raphiniert.png alt="Raphael Scheible | Follower of Jesus Christ | Computer Scientist | Researcher - Raphiniert.com"></a></div><button type=button class=navbar-toggler data-toggle=collapse data-target=#navbar-content aria-controls=navbar aria-expanded=false aria-label="Toggle navigation">
<span><i class="fas fa-bars"></i></span></button><div class="navbar-brand-mobile-wrapper d-inline-flex d-lg-none"><a class=navbar-brand href=/><img src=/img/raphiniert.png alt="Raphael Scheible | Follower of Jesus Christ | Computer Scientist | Researcher - Raphiniert.com"></a></div><div class="navbar-collapse main-menu-item collapse justify-content-center" id=navbar-content><ul class="navbar-nav d-md-inline-flex"><li class=nav-item><a class=nav-link href=/#about><span>Home</span></a></li><li class=nav-item><a class=nav-link href=/#projects><span>Projects</span></a></li><li class=nav-item><a class=nav-link href=/#publications><span>Publications</span></a></li><li class=nav-item><a class=nav-link href=/jesus><span>Spiritual Life</span></a></li><li class=nav-item><a class=nav-link href=/#contact><span>Contact</span></a></li></ul></div><ul class="nav-icons navbar-nav flex-row ml-auto d-flex pl-md-2"><li class=nav-item><a class="nav-link js-search" href=#><i class="fas fa-search" aria-hidden=true></i></a></li></ul></div></nav><div class=pub><div class="article-container pt-3"><h1>Activated Phosphoinositide 3-Kinase δ Syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity</h1><div class=article-metadata><div><span>Maria Elena Maccari</span>, <span>Martin Wolkewitz</span>, <span>Charlotte Schwab</span>, <span>Tiziana Lorenzini</span>, <span>Jennifer W. Leiding</span>, <span>Nathalie Aladjdi</span>, <span>Hassan Abolhassani</span>, <span>Wadih Abou-Chahla</span>, <span>Alessandro Aiuti</span>, <span>Saba Azarnoush</span>, <span>Safa Baris</span>, <span>Vincent Barlogis</span>, <span>Federica Barzaghi</span>, <span>Ulrich Baumann</span>, <span>Marketa Bloomfield</span>, <span>Nadezda Bohynikova</span>, <span>Damien Bodet</span>, <span>David Boutboul</span>, <span>Giorgia Bucciol</span>, <span>Matthew S. Buckland</span>, <span>Siobhan O. Burns</span>, <span>Caterina Cancrini</span>, <span>Pascal Cathébras</span>, <span>Marina Cavazzana</span>, <span>Morgane Cheminant</span>, <span>Matteo Chinello</span>, <span>Peter Ciznar</span>, <span>Tanya I. Coulter</span>, <span>Maud D’Aveni</span>, <span>Olov Ekwall</span>, <span>Zelimir Eric</span>, <span>Efrem Eren</span>, <span>Anders Fasth</span>, <span>Pierre Frange</span>, <span>Benjamin Fournier</span>, <span>Marina Garcia-Prat</span>, <span>Martine Gardembas</span>, <span>Christoph Geier</span>, <span>Sujal Ghosh</span>, <span>Vera Goda</span>, <span>Lennart Hammarstrom</span>, <span>Fabian Hauck</span>, <span>Maximilian Heeg</span>, <span>Edyta Heropolitanska-Pliszka</span>, <span>Anna Hilfanova</span>, <span>Stephen Jolles</span>, <span>Elif Karakoc-Aydiner</span>, <span>Gerhard R. Kindle</span>, <span>Christian Klemann</span>, <span>Patra Koletsi</span>, <span>Sylwia Koltan</span>, <span>Irina Kondratenko</span>, <span>Julia Körholz</span>, <span>Renate Krüger</span>, <span>Eric Jeziorski</span>, <span>Romain Levy</span>, <span>Guillaume Le Guenno</span>, <span>Guillaume Lefevre</span>, <span>Vassilios Lougaris</span>, <span>Antonio Marzollo</span>, <span>Nizar Mahlaoui</span>, <span>Marion Malphettes</span>, <span>Andrea Meinhardt</span>, <span>Etienne Merlin</span>, <span>Isabelle Meyts</span>, <span>Tomas Milota</span>, <span>Fernando Moreira</span>, <span>Despina Moshous</span>, <span>Anna Mukhina</span>, <span>Olaf Neth</span>, <span>Jennifer Neubert</span>, <span>Benedicte Neven</span>, <span>Alexandra Nieters</span>, <span>Raphaele Nove-Josserand</span>, <span>Eric Oksenhendler</span>, <span>Ahmet Ozen</span>, <span>Peter Olbrich</span>, <span>Antoinette Perlat</span>, <span>Malgorzata Pac</span>, <span>Jana Pachlopnik Schmid</span>, <span>Lucia Pacillo</span>, <span>Alba Parra-Martinez</span>, <span>Olga Paschenko</span>, <span>Isabelle Pellier</span>, <span>Asena Pinar Sefer</span>, <span>Alessandro Plebani</span>, <span>Dominique Plantaz</span>, <span>Seraina Prader</span>, <span>Loic Raffray</span>, <span>Henrike Ritterbusch</span>, <span>Jacques G. Riviere</span>, <span>Beatrice Rivalta</span>, <span>Stephan Rusch</span>, <span>Inga Sakovich</span>, <span>Sinisa Savic</span>, <span>Raphael Scheible</span>, <span>Nicolas Schleinitz</span>, <span>Catharina Schuetz</span>, <span>Ansgar Schulz</span>, <span>Anna Sediva</span>, <span>Michaela Semeraro</span>, <span>Svetlana O. Sharapova</span>, <span>Anna Shcherbina</span>, <span>Mary A. Slatter</span>, <span>Georgios Sogkas</span>, <span>Pere Soler-Palacin</span>, <span>Carsten Speckmann</span>, <span>Jean-Louis Stephan</span>, <span>Felipe Suarez</span>, <span>Alberto Tommasini</span>, <span>Johannes Trück</span>, <span>Annette Uhlmann</span>, <span>Koen J. van Aerde</span>, <span>Joris van Montfrans</span>, <span>Horst von Bernuth</span>, <span>Klaus Warnatz</span>, <span>Tony Williams</span>, <span>Austen JJ. Worth</span>, <span>Winnie Ip</span>, <span>Capucine Picard</span>, <span>Emilie Catherinot</span>, <span>Zohreh Nademi</span>, <span>Bodo Grimbacher</span>, <span>Lisa R. Forbes Satter</span>, <span>Sven Kracker</span>, <span>Anita Chandra</span>, <span>Alison M. Condliffe</span>, <span>Stephan Ehl</span></div><span class=article-date>June 2023</span></div><div class="btn-links mb-3"><button type=button class="btn btn-outline-primary my-1 mr-1 js-cite-modal" data-filename=/publication/maccari-activated-2023/cite.bib>
Cite</button>
<a class="btn btn-outline-primary my-1 mr-1" href=https://doi.org/10.1016/j.jaci.2023.06.015 target=_blank rel=noopener>DOI</a>
<a class="btn btn-outline-primary my-1 mr-1" href=https://www.sciencedirect.com/science/article/pii/S0091674923008126 target=_blank rel=noopener>URL</a></div></div><div class=article-container><h3>Abstract</h3><p class=pub-abstract>Background Activated phosphoinositide-3-kinase (PI3K) δ Syndrome (APDS) is an inborn error of immunity (IEI) with infection susceptibility and immune dysregulation, clinically overlapping with other conditions. Management depends on disease evolution, but predictors of severe disease are lacking. Objectives Report the extended spectrum of disease manifestations in APDS1 versus APDS2, compare these to CTLA-4 deficiency, NFκB1 deficiency, and STAT3 gain-of-function (GOF) disease; identify predictors of severity in APDS. Methods Data collection with the European Society for Immunodeficiencies (ESID)-APDS registry. Comparison with published cohorts of the other IEIs. Results The analysis of 170 APDS patients outlines high penetrance and early-onset of APDS compared to the other IEIs. The large clinical heterogeneity even in individuals with the same PIK3CD variant E1021K illustrates how poorly the genotype predicts the disease phenotype and course. The high clinical overlap between APDS and the other investigated IEIs suggests relevant pathophysiological convergence of the affected pathways. Preferentially affected organ systems indicate specific pathophysiology: bronchiectasis is typical of APDS1; interstitial lung disease and enteropathy are more common in STAT3 GOF and CTLA-4 deficiency. Endocrinopathies are most frequent in STAT3 GOF, but growth impairment is also common particularly in APDS2. Early clinical presentation is a risk factor for severe disease in APDS. Conclusion APDS illustrates how a single genetic variant can result in a diverse autoimmune-lymphoproliferative phenotype. Overlap with other IEI is substantial. Some specific features distinguish APDS1 from APDS2. Early-onset is a risk factor for severe disease course calling for specific treatment studies in younger patients.</p><div class=row><div class=col-md-1></div><div class=col-md-10><div class=row><div class="col-12 col-md-3 pub-row-heading">Type</div><div class="col-12 col-md-9"><a href=/publication/#2>Journal article</a></div></div></div><div class=col-md-1></div></div><div class="d-md-none space-below"></div><div class=space-below></div><div class=article-style></div><div class=article-tags><a class="badge badge-light" href=/tags/apds/>APDS</a>
<a class="badge badge-light" href=/tags/ctla-4/>CTLA-4</a>
<a class="badge badge-light" href=/tags/esid/>ESID</a>
<a class="badge badge-light" href=/tags/iei/>IEI</a>
<a class="badge badge-light" href=/tags/immunodeficiency/>immunodeficiency</a>
<a class="badge badge-light" href>NFκB1</a>
<a class="badge badge-light" href=/tags/pi3k/>PI3K</a>
<a class="badge badge-light" href=/tags/pik3cd/>PIK3CD</a>
<a class="badge badge-light" href=/tags/pik3r1/>PIK3R1</a>
<a class="badge badge-light" href=/tags/stat3/>STAT3</a></div><div class=share-box aria-hidden=true><ul class=share><li><a href="https://twitter.com/intent/tweet?url=https://raphiniert.com/publication/maccari-activated-2023/&amp;text=Activated%20Phosphoinositide%203-Kinase%20%ce%b4%20Syndrome:%20Update%20from%20the%20ESID%20Registry%20and%20comparison%20with%20other%20autoimmune-lymphoproliferative%20inborn%20errors%20of%20immunity" target=_blank rel=noopener class=share-btn-twitter><i class="fab fa-twitter"></i></a></li><li><a href="https://www.facebook.com/sharer.php?u=https://raphiniert.com/publication/maccari-activated-2023/&amp;t=Activated%20Phosphoinositide%203-Kinase%20%ce%b4%20Syndrome:%20Update%20from%20the%20ESID%20Registry%20and%20comparison%20with%20other%20autoimmune-lymphoproliferative%20inborn%20errors%20of%20immunity" target=_blank rel=noopener class=share-btn-facebook><i class="fab fa-facebook"></i></a></li><li><a href="mailto:?subject=Activated%20Phosphoinositide%203-Kinase%20%ce%b4%20Syndrome:%20Update%20from%20the%20ESID%20Registry%20and%20comparison%20with%20other%20autoimmune-lymphoproliferative%20inborn%20errors%20of%20immunity&amp;body=https://raphiniert.com/publication/maccari-activated-2023/" target=_blank rel=noopener class=share-btn-email><i class="fas fa-envelope"></i></a></li><li><a href="https://www.linkedin.com/shareArticle?url=https://raphiniert.com/publication/maccari-activated-2023/&amp;title=Activated%20Phosphoinositide%203-Kinase%20%ce%b4%20Syndrome:%20Update%20from%20the%20ESID%20Registry%20and%20comparison%20with%20other%20autoimmune-lymphoproliferative%20inborn%20errors%20of%20immunity" target=_blank rel=noopener class=share-btn-linkedin><i class="fab fa-linkedin-in"></i></a></li><li><a href="https://web.whatsapp.com/send?text=Activated%20Phosphoinositide%203-Kinase%20%ce%b4%20Syndrome:%20Update%20from%20the%20ESID%20Registry%20and%20comparison%20with%20other%20autoimmune-lymphoproliferative%20inborn%20errors%20of%20immunity%20https://raphiniert.com/publication/maccari-activated-2023/" target=_blank rel=noopener class=share-btn-whatsapp><i class="fab fa-whatsapp"></i></a></li><li><a href="https://service.weibo.com/share/share.php?url=https://raphiniert.com/publication/maccari-activated-2023/&amp;title=Activated%20Phosphoinositide%203-Kinase%20%ce%b4%20Syndrome:%20Update%20from%20the%20ESID%20Registry%20and%20comparison%20with%20other%20autoimmune-lymphoproliferative%20inborn%20errors%20of%20immunity" target=_blank rel=noopener class=share-btn-weibo><i class="fab fa-weibo"></i></a></li></ul></div><div class="media author-card content-widget-hr"><div class=media-body><h5 class=card-title><a href=/authors/maria-elena-maccari/></a></h5><ul class=network-icon aria-hidden=true></ul></div></div></div></div><script src=https://cdnjs.cloudflare.com/ajax/libs/jquery/3.4.1/jquery.min.js integrity="sha256-CSXorXvZcTkaix6Yvo6HppcZGetbYMGWSFlBw8HfCJo=" crossorigin=anonymous></script><script src=https://cdnjs.cloudflare.com/ajax/libs/jquery.imagesloaded/4.1.4/imagesloaded.pkgd.min.js integrity="sha256-lqvxZrPLtfffUl2G/e7szqSvPBILGbwmsGE1MKlOi0Q=" crossorigin=anonymous></script><script src=https://cdnjs.cloudflare.com/ajax/libs/jquery.isotope/3.0.6/isotope.pkgd.min.js integrity="sha256-CBrpuqrMhXwcLLUd5tvQ4euBHCdh7wGlDfNz8vbu/iI=" crossorigin=anonymous></script><script src=https://cdnjs.cloudflare.com/ajax/libs/fancybox/3.5.7/jquery.fancybox.min.js integrity="sha256-yt2kYMy0w8AbtF89WXb2P1rfjcP/HTHLT7097U8Y5b8=" crossorigin=anonymous></script><script src=https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.15.10/highlight.min.js integrity="sha256-1zu+3BnLYV9LdiY85uXMzii3bdrkelyp37e0ZyTAQh0=" crossorigin=anonymous></script><script src=https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.15.10/languages/r.min.js></script><script src=https://cdnjs.cloudflare.com/ajax/libs/leaflet/1.5.1/leaflet.js integrity="sha256-EErZamuLefUnbMBQbsEqu1USa+btR2oIlCpBJbyD4/g=" crossorigin=anonymous></script><script>const code_highlighting=true;</script><script>const search_config={"indexURI":"/index.json","minLength":1,"threshold":0.3};const i18n={"no_results":"No results found","placeholder":"Search...","results":"results found"};const content_type={'post':"Posts",'project':"Projects",'publication':"Publications",'talk':"Talks"};</script><script id=search-hit-fuse-template type=text/x-template>
      <div class="search-hit" id="summary-{{key}}">
      <div class="search-hit-content">
        <div class="search-hit-name">
          <a href="{{relpermalink}}">{{title}}</a>
          <div class="article-metadata search-hit-type">{{type}}</div>
          <p class="search-hit-description">{{snippet}}</p>
        </div>
      </div>
      </div>
    </script><script src=https://cdnjs.cloudflare.com/ajax/libs/fuse.js/3.2.1/fuse.min.js integrity="sha256-VzgmKYmhsGNNN4Ph1kMW+BjoYJM2jV5i4IlFoeZA9XI=" crossorigin=anonymous></script><script src=https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/jquery.mark.min.js integrity="sha256-4HLtjeVgH0eIB3aZ9mLYF6E8oU5chNdjU6p6rrXpl9U=" crossorigin=anonymous></script><script src=/js/academic.min.600a2e440c16093e23e26e90951c4d4b.js></script><div class=container><footer class=site-footer><p class=powered-by><a href=/privacy/>Datenschutzerklärung</a>
&middot;
<a href=/terms/>Impressum</a></p><p class=powered-by>&copy; 2024 Raphael Scheible
<span class=float-right aria-hidden=true><a href=# class=back-to-top><span class=button_icon><i class="fas fa-chevron-up fa-2x"></i></span></a></span></p></footer></div><div id=modal class="modal fade" role=dialog><div class=modal-dialog><div class=modal-content><div class=modal-header><h5 class=modal-title>Cite</h5><button type=button class=close data-dismiss=modal aria-label=Close>
<span aria-hidden=true>&times;</span></button></div><div class=modal-body><pre><code class="tex hljs"></code></pre></div><div class=modal-footer><a class="btn btn-outline-primary my-1 js-copy-cite" href=# target=_blank><i class="fas fa-copy"></i>Copy</a>
<a class="btn btn-outline-primary my-1 js-download-cite" href=# target=_blank><i class="fas fa-download"></i>Download</a><div id=modal-error></div></div></div></div></div></body></html>